99 results on '"Straka, Robert J."'
Search Results
2. Effect of ginger supplementation on the fecal microbiome in subjects with prior colorectal adenoma
3. Development and application of pharmacological statin-associated muscle symptoms phenotyping algorithms using structured and unstructured electronic health records data
4. Development and validation of the pharmacological statin-associated muscle symptoms risk stratification (PSAMS-RS) score using real-world electronic health record data
5. Population pharmacokinetics, pharmacodynamics and pharmacogenetics modelling of oxypurinol in Hmong adults with gout and/or hyperuricemia
6. Development and Application of Pharmacological Statin-Associated Muscle Symptoms Phenotyping Algorithms Using Structured and Unstructured Electronic Health Records Data
7. Hmong microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C): A phase II clinical study protocol
8. Pharmacogenomic variabilities in geo-ancestral subpopulations and their clinical implications: Results of collaborations with Hmong in the United States
9. Comparison of the Warfarin Dosing and Outcomes in Hmong Versus East Asians Patients: Real-World Data From an Integrated Healthcare System
10. PharmVar GeneFocus :SLCO1B1
11. The Identification of Novel CYP2D6 Variants in US Hmong: Results From Genome Sequencing and Clinical Genotyping
12. The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin‐Associated Musculoskeletal Symptoms
13. Pharmacogenomics education, research and clinical implementation in the state of Minnesota
14. Gout prevalence in the Hmong: a prime example of health disparity and the role of community-based genetic research
15. Differences in Predicted Warfarin Dosing Requirements Between Hmong and East Asians Using Genotype‐Based Dosing Algorithms
16. Abstract A26: Pilot trial to examine the effect of ginger on the gut microbiome: The Minnesota Cancer Clinical Trials Network
17. Randomised clinical study: oral aspirin 325 mg daily vs placebo alters gut microbial composition and bacterial taxa associated with colorectal cancer risk
18. Salivary AMY1 Copy Number Variation Modifies Age-Related Type 2 Diabetes Risk
19. HLA-B*58:01 carrier status of Hmong in Minnesota: first in Hmong genotyping for prevalence of this biomarker of risk for severe cutaneous adverse reactions caused by allopurinol
20. Potential Clinical Relevance of Differences in Allele Frequencies Found within Very Important Pharmacogenes between Hmong and East Asian Populations
21. Abstract 5060: Effect of aspirin on gut microbiome in a pilot randomized double-blind trial
22. Abstract 5060: Effect of aspirin on gut microbiome in a pilot randomized double-blind trial
23. An Exome-Wide Sequencing Study of the GOLDN Cohort Reveals Novel Associations of Coding Variants and Fasting Plasma Lipids
24. Precision medicine in adult and pediatric obesity: a clinical perspective
25. An exome-wide sequencing study of lipid response to high-fat meal and fenofibrate in Caucasians from the GOLDN cohort
26. Sex Differences in Blood HDL‐c, the Total Cholesterol/HDL‐c Ratio, and Palmitoleic Acid are Not Associated with Variants in Common Candidate Genes
27. Potential Clinical and Economic Impact of Switching Branded Medications to Generics
28. Engaging Hmong adults in genomic and pharmacogenomic research: Toward reducing health disparities in genomic knowledge using a community-based participatory research approach
29. Leaves imitate trees: Minnesota Hmong concepts of heredity and applications to genomics research
30. Assessment of postprandial triglycerides in clinical practice: Validation in a general population and coronary heart disease patients
31. Assessment of genetic polymorphisms associated with hyperuricemia or gout in the Hmong
32. A genome-wide study of lipid response to fenofibrate in Caucasians
33. A family-specific linkage analysis of blood lipid response to fenofibrate in the Genetics of Lipid Lowering Drug and Diet Network
34. Ethnic and genetic factors in methadone pharmacokinetics: A population pharmacokinetic study
35. A 16-Month Community-Based Intervention to Increase Aspirin Use for Primary Prevention of Cardiovascular Disease
36. Abstract 537: Higher Prevalence of Risk Alleles for Hyperuricemia Parallels Elevated Incidence of Gout and Growing Risk for Cardiovascular Diseases in a Hmong Population
37. Abstract 194: Differential Prevalence of Loss/Gain of Function Alleles Affecting Response to Clopidogrel in the Hmong Underscores the Importance of Genotyping Unique Subpopulations as a Means to Address Existing Health Disparities
38. Genome-wide association studies identified novel loci for non-high-density lipoprotein cholesterol and its postprandial lipemic response
39. Student-generated, faculty-vetted multiple-choice questions: Value, participant satisfaction, and workload
40. Abstract MP31: DNA Methylation Patterns are Associated with Genetic Variation and Systemic Inflammation
41. Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies
42. Genetic variants associated with VLDL, LDL and HDL particle size differ with race/ethnicity
43. Genetic Analysis of 16 NMR-Lipoprotein Fractions in Humans, the GOLDN Study
44. Variants Identified in a GWAS Meta-Analysis for Blood Lipids Are Associated with the Lipid Response to Fenofibrate
45. Genome-wide association study indicates variants associated with insulin signaling and inflammation mediate lipoprotein responses to fenofibrate
46. Abstract 141: APOA1, CETP, and CILP2 Variants Modify the Lipid Response to Fenofibrate: Genetics of Lipid Lowering and Diet Network
47. Rare PPARA variants and extreme response to fenofibrate in the Genetics of Lipid-Lowering Drugs and Diet Network Study
48. Abstract 20: Evidence of UGT2B7 as a Pharmacogenetic Determinant of Variability in Serum Fenofibric Acid Levels in Human Subjects
49. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study
50. Abstract P228: Genome-Wide Association Study of Lipid Response to Fenofibrate Treatment in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN) Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.